No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
PYXS240719C12500
- 0.65
- 0.000.00%
15min DelayClose Jul 12 10:36 ET
0.00High0.00Low
0.65Open0.65Pre Close0 Volume41 Open Interest12.50Strike Price0.00Turnover1028.38%IV317.46%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.65Extrinsic Value100Contract SizeAmericanOptions Type0.3893Delta0.0868Gamma4.85Leverage Ratio-0.1271Theta0.0001Rho1.89Eff Leverage0.0016Vega
Intraday
- 5D
- Daily
News
Institutional Owners May Ignore Pyxis Oncology, Inc.'s (NASDAQ:PYXS) Recent US$25m Market Cap Decline as Longer-term Profits Stay in the Green
Express News | Pyxis Oncology Expands Board of Directors With Appointment of Michael a. Metzger
Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS), Hims & Hers Health (HIMS) and Cytokinetics (CYTK)
Pyxis Oncology | 10-Q: Quarterly report
Pyxis Oncology 1Q Research and Development Expenses $13.0M >PYXS
Pyxis Oncology 1Q Research and Development Expenses $13.0M >PYXS
Pyxis Oncology 1Q Loss/Shr 6c >PYXS
Pyxis Oncology 1Q Loss/Shr 6c >PYXS
Comments
The insider transactions at Pyxis Oncology do not provide much encouragement. However, the fact that insiders own a significant portion of the company suggests a reasonable degree of alignment with other shareholders.
Insiders Who Sold Pyxis Oncology Made The Right Call As Market Cap Slides By US$50m 1
Pyxis Oncology Announces $50 Million Private Placement: Urgent Developments in Cancer Research.
In an urgent and significant development in the field of oncology research, Pyxis Oncology (NASDAQ: $PYXS) recently announced a $50 million private placement. This news comes as a major step forward for the company and its efforts to advance the development of new cancer treatments. $Pyxis Oncology(PYXS.US$
https://stockregion.app/p/oncology-research-company-secures
In an urgent and significant development in the field of oncology research, Pyxis Oncology (NASDAQ: $PYXS) recently announced a $50 million private placement. This news comes as a major step forward for the company and its efforts to advance the development of new cancer treatments. $Pyxis Oncology(PYXS.US$
https://stockregion.app/p/oncology-research-company-secures
$Pyxis Oncology(PYXS.US$
Plus the dude who analyzed the target price has a 100% success rate in his analyses! He's not a dummy ^^
Plus the dude who analyzed the target price has a 100% success rate in his analyses! He's not a dummy ^^
$Pyxis Oncology(PYXS.US$
top gainers yesterday, I cheked it and I think it has great potential.
"strong buy"
top gainers yesterday, I cheked it and I think it has great potential.
"strong buy"
Read more